SCHEMBL2932340

SCHEMBL2932340

COC(=O)C(C)(C)Oc1cc(C)c(CNc2nc(-c3ccc(C(F)(F)F)cc3)cs2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GSTO1 P78417 1/20 0.46
PPARD Q03181 6/20 0.45
PPARA Q07869 5/20 0.44
PPARG P37231 3/20 0.44
TRPA1 O75762 2/20 0.41
TRPV4 Q9HBA0 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
WNT3A P56704 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906440 0.92 PPARD (0.50) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2900862 0.81 PPARD (0.54) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL4187098 0.79 PPARD (0.47) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2906603 0.79 PPARD (0.48) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2908805 0.78 KDM1A (0.56) ALDH1A1PPARDMEN1KMT2AUSP2
SCHEMBL2901181 0.78 PPARD (0.47) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2900976 0.78 PPARD (0.47) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2903594 0.76 PPARD (0.49) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2903604 0.75 PPARD (0.45) ALDH1A1L3MBTL1GSTO1PPARDPPARA
SCHEMBL2906629 0.75 PPARD (0.48) ALDH1A1L3MBTL1GSTO1PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP disclosed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR PPARD, PPARG, PPARA ALDH1A1 815/4885L3MBTL1 4013/4885GSTO1 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.